Cancer Diagnostics articles & resources on Made-in-China.com

Cancer Diagnostics to Drive Coherence Tomography Market Growth

Nov 5, 2015

The emergence of applications in cancer diagnostics, cardiology and gastroenterology will help drive the market for clinical optical imaging to $2 billion by the end of the decade. That’s according to a new market report from the ...

Tags: Cancer Diagnostics, optical technologies, ultrasound technologies

SGH Resulted in The Establishment of The Region's First Circulating Tumour Cell Centre

Jan 19, 2014

A collaboration between National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Department at Singapore General Hospital (SGH) has resulted in the establishment of the region's first Circulating ...

Tags: Health, Medicine

Scientists Say They May Have Found a Way to Predict Survival From Ovarian Cancer

Dec 26, 2013

By counting the number of cancer-fighting immune cells inside tumors, scientists say they may have found a way to predict survival from ovarian cancer. The researchers developed an experimental method to count these cells, called ...

Tags: Health, Medicine, Cancer

Digital Pathology Solution for Breast Cancer Diagnostics Is Introduced by Dako and Omnyx

Sep 3, 2013

Dako, a Danish provider of tissue-based cancer diagnostics, and Omnyx, a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, have launched clinical image analysis for digital pathology in Europe. As part of the ...

Tags: Health, Medicine, digital pathology

Dako Has Entered Into Collaboration Agreement with Pfizer

Feb 19, 2013

Denmark-based cancer diagnostics solutions manufacturer Dako announced that it has entered into collaboration agreement with Pfizer in the field of companion diagnostics. The agreement includes a legal framework for various collaboration ...

Tags: cancer diagnostics solutions, Dako, Pfizer

Clarient Has Entered Into an Agreement for Lung Cancer From Insight Genetics

Dec 18, 2012

Clarient Diagnostic Services, a GE Healthcare company, has entered into an agreement to license genomic biomarker for lung cancer from Insight Genetics. AS per the agreement, Clarient intends to develop and assess the performance ...

Tags: Lung Cancer, cooperation, medical technology

Dako Received Approval From The US Food and Drug Administration

Dec 5, 2012

Dako, a manufacturer of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest and Her2 Fish pharmDx kit as co diagnostics for pertuzumab (Perjeta), a Genentech cancer drug. ...

Tags: Dako, HER2-positive metastatic breast cance, HER2 FISH pharmDx Kit

Quest Diagnostics Has Introduced a Molecular Cervical Cancer Test

Dec 4, 2012

Quest Diagnostics has introduced a molecular cervical cancer test based on National Institutes of Health's TERC gene marker to identify molecular changes to cervical cells that increase the chance of a woman to develop cervical cancer. ...

Tags: cervical cancer TERC test, Quest Diagnostics, TERC results

CHUFT Has Reported Savings of About£45,000 and Saved 115 More Lives

Sep 13, 2012

Colchester Hospital University NHS Foundation Trust(CHUFT)has reported savings of about£45,000 and saved 115 more lives since implementing a suite of QlikView applications last year. In 2010,the trust had a problem with its ...

Tags: Colchester Hospital University, NHS Trust, CHUFT, Department of Health

FDA Approval Herceptest and Her2 Fish Fish Diagnostic Tools Has Been Received by Dako

Jun 12, 2012

Dako, a Danish provider of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest and HER2 FISH pharmDx Kit as companion diagnostics for pertuzumab (Perjeta) - a new Genentech ...

Tags: Dako, cancer diagnostics solutions, HercepTest, HER2 FISH

Agendia Introduces ColoPrint Microarray-Based 18-Gene Expression Assay

Jun 4, 2012

The molecular cancer diagnostics company, Agendia, has introduced ColoPrint microarray-based 18-gene expression assay. The ColoPrint assay is designed for predicting the risk of distant recurrence for stage II colon cancer patients who ...

Tags: molecular cancer diagnostics, expression assay, cancer diagnostics

Cancer Diagnostics

Related Products